Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 19, 2023
Date Accepted: Jun 18, 2024

The final, peer-reviewed published version of this preprint can be found here:

A Machine Learning Model for Predicting In-Hospital Mortality in Chinese Patients With ST-Segment Elevation Myocardial Infarction: Findings From the China Myocardial Infarction Registry

Yang J, Li Y, Li X, Tao S, Zhang Y, Chen T, Xie G, Xu H, Gao X, Yang Y

A Machine Learning Model for Predicting In-Hospital Mortality in Chinese Patients With ST-Segment Elevation Myocardial Infarction: Findings From the China Myocardial Infarction Registry

J Med Internet Res 2024;26:e50067

DOI: 10.2196/50067

PMID: 39079111

PMCID: 11322712

An Explainable and Flexible Machine Learning Risk Prediction Model for In-hospital Mortality in Chinese STEMI Patients: Findings from China Myocardial Infarction Registry

  • Jingang Yang; 
  • Yingxue Li; 
  • Xiang Li; 
  • Shuiying Tao; 
  • Yuan Zhang; 
  • Tiange Chen; 
  • Guotong Xie; 
  • Haiyan Xu; 
  • Xiaojin Gao; 
  • Yuejin Yang

ABSTRACT

Aims: Machine learning (ML) risk prediction models, although much more accurate than traditional statistical methods, were inconvenient to use in clinical practice due to its non-transparency and requirements of a big number of input variables. We aimed to develop a precise, explainable and flexible ML model to predict the risk of in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI). Methods &

Results:

The study recruited 18, 744 patients enrolled in the China Acute Myocardial Infarction (CAMI) registry and 12, 018 patients in the China PEACE-Retrospective Acute Myocardial Infarction Study. The Extreme Gradient Boosting (XGBoost) was derived on the 9616 patients in CAMI registry (Year 2014, 89 variables) with 5-fold cross validation and validated on both the 9125 patients in CAMI registry (Year 2015, 89 variables) and the independent China PEACE cohort (10 variables). The SHapley Additive exPlanations (SHAP) approach was employed to interpret the complex relationships embedded in the proposed model. The Area Under the Curve (AUC) on the CAMI validation set was 0.896 (95% CI: 0.884-0.909) on the CAMI validation set, significantly higher than the previous models (GRACE: 0.809, 95%CI: 0.790-0.828; TIMI: 0.782 ,95% CI: 0.763-0.800). Although the China PEACE validation set only has ten available variables, the AUC on the China PEACE validation set still reached 0.840 (0.829-0.852), which improved substantially to the GRACE (0.762, 95% CI: 0.748-0.776) and TIMI (0.789, 95% CI:0.776-0.803]. Several novel and non-linear relationships such as the U-shape pattern of HDL-C were discovered between the patients’ characteristics and the in-hospital mortality. Conclusion: The proposed ML risk prediction model was highly accurate to predict the in-hospital mortality. The flexible and explainable characteristics makes the model convenient to use in clinical practice and could help to guide the patient management.


 Citation

Please cite as:

Yang J, Li Y, Li X, Tao S, Zhang Y, Chen T, Xie G, Xu H, Gao X, Yang Y

A Machine Learning Model for Predicting In-Hospital Mortality in Chinese Patients With ST-Segment Elevation Myocardial Infarction: Findings From the China Myocardial Infarction Registry

J Med Internet Res 2024;26:e50067

DOI: 10.2196/50067

PMID: 39079111

PMCID: 11322712

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.